10x Genomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 12, 2025

PLEASANTON, Calif., Jan. 28, 2025 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the fourth quarter and full year ended December 31, 2024 after market close on Wednesday, February 12, 2025. The…

error: Content is protected !!